Press Releases

Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

Jan 17, 2017

Interpace Diagnostics Announces $4.2 Million Registered Direct Offering of Common Stock

Jan 3, 2017

Interpace Diagnostics Group Announces 1-for-10 Reverse Split

Dec 28, 2016

Interpace Diagnostics Announces $1.9 Million Registered Direct Offering of Common Stock

Dec 19, 2016

Interpace Diagnostics Announces New Aetna Coverage Policy

Dec 8, 2016

Interpace Diagnostics Reports Third Quarter 2016 Results of Operations

Nov 18, 2016

Evidence Supporting Interpace Diagnostics' PanDNA® Product Presented at the American College of Gastroenterology Annual Meeting

Oct 19, 2016

Interpace Diagnostics Launches New Services for Indeterminate Thyroid Nodules

Oct 13, 2016

Interpace Diagnostics Launches New Streamlined Molecular Product for Pancreatic Cysts

Oct 6, 2016

Interpace Diagnostics Invited to Present Data at Upcoming American Thyroid Association (ATA) Annual Meeting

Sep 12, 2016